Abstract
BackgroundCD8+ T cells impact control of viral infections by direct elimination of infected cells and secretion of a number of soluble factors. In HIV-1 infection, persistent HIV-1 specific IFN-γ+ CD8+ T cell responses are detected in the setting of disease progression, consistent with functional impairment in vivo. Recent data suggest that impaired maturation, as defined by the lineage markers CD45RA and CCR7, may contribute to a lack of immune control by these responses.Methodology/Principal FindingsWe investigated the maturation phenotype of epitope-specific CD8+ T cell responses directed against HIV-1 in 42 chronically infected, untreated individuals, 22 of whom were “Controllers” (median 1140 RNA copies/ml plasma, range<50 to 2520), and 20 “progressors” of whom had advanced disease and high viral loads (median 135,500 RNA copies/ml plasma, range 12100 to >750000). Evaluation of a mean of 5 epitopes per person revealed that terminally differentiated CD8+ T cells directed against HIV-1 are more often seen in HIV-1 Controllers (16/22; 73%) compared to HIV-1 progressors (7/20; 35%)(p = 0.015), but the maturation state of epitope-specific responses within a given individual was quite variable. Maturation phenotype was independent of the HLA restriction or the specificity of a given CD8+ T cell response and individual epitopes associated with slow disease progression were not more likely to be terminally differentiated.Conclusions/SignificanceThese data indicate that although full maturation of epitope-specific CD8+ T cell responses is associated with viral control, the maturation status of HIV-1 specific CD8+ T cell responses within a given individual are quite heterogeneous, suggesting epitope-specific influences on CD8+ T cell function.
Highlights
An increasing body of evidence suggests that HIV-1 specific T cells contribute to viral control in HIV-1 infection
A differentiation block from effector memory cells (CCR72/CCD45RA2) to terminally differentiated effector cells (CCR72/CD45RA+) has been reported in chronic progressive HIV-1 infection, resulting in a relative paucity of fully mature virus-specific effector CD8+ T cells [20,27]. Based on this model and the lack of quantitative differences in the HIV-1 specific cellular immune response measured by IFN-c secretion described above [14,26], we hypothesized that HIV-1 Controllers would posses significantly higher numbers of terminally differentiated CD8+ T cells in directly isolated peripheral blood mononuclear cells (PBMC) compared to HIV-1 Progressors
Terminally differentiated CD45RA+/CCR72 HIV-1-specific CD8+ T cells were significantly more frequently detectable in HIV-1 Controllers than in HIV-1 progressors, and contributed an average of 32% to the total HIV-1-specific CD8+ T cell response in HIV-1-Controllers, compared to only 11% in progressors. These data indicate that qualitative rather than quantitative characteristics of HIV-1-specific CD8+ T cell responses may be associated with differences in viral control and HIV-1 disease outcome
Summary
An increasing body of evidence suggests that HIV-1 specific T cells contribute to viral control in HIV-1 infection. HIV-1 specific CD8+ T cells persist in high numbers in persons with untreated chronic progressive disease and no quantitative differences in the HIV-1 specific T cell response were observed between individuals with progressive and long-term non-progressive infection [14,15,16]. These findings suggest that CD8+ T cell characteristics that determine differences in HIV-1 disease outcomes may be of a qualitative rather than a quantitative nature. These data indicate that full maturation of epitope-specific CD8+ T cell responses is associated with viral control, the maturation status of HIV-1 specific CD8+ T cell responses within a given individual are quite heterogeneous, suggesting epitope-specific influences on CD8+ T cell function
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have